Cargando…

Neuropsychiatric assessments in patients with multiple sclerosis in early phases and with low disability

BACKGROUND: In the early phases of multiple sclerosis (MS), patients exhibit slight neuropsychiatric deficits that can only be detected using reliable tools. AIM: The present investigation aimed to examine neuropsychological performance in 35 patients with incipient MS. PATIENTS AND METHODS: For the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schmidt, Sergio L, Santos da Silva, Michele, Schmidt, Juliana J, Carvalho, Ana Lucia Novais, Vasconcelos, Claudia Cristina Ferreira, Paes, Renata Alves, Boechat, Yolanda EM, Neder, Rafael, Alvarenga, Regina P
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2018
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6018925/ https://www.ncbi.nlm.nih.gov/pubmed/29950848 http://dx.doi.org/10.2147/NDT.S163480

Ejemplares similares

Neuromyelitis optica is an HLA associated disease different from Multiple Sclerosis: a systematic review with meta-analysis
por: Alvarenga, Marcos Papais, et al.
Publicado: (2021)

Age, motor dysfunction and neuropsychiatric symptoms impact quality of life in multiple sclerosis
por: Brandão, Patrícia de Morais Ferreira, et al.
Publicado: (2022)

Voxel-based morphometry findings in Alzheimer's disease: neuropsychiatric symptoms and disability correlations – preliminary results
por: de Gois Vasconcelos, Luciano, et al.
Publicado: (2011)

The relationship between multiple sclerosis and neuropsychiatric syndromes
por: McLoughlin, James, et al.
Publicado: (2017)

Neuropsychiatric Symptoms of Multiple Sclerosis: State of the Art
por: Silveira, Celeste, et al.
Publicado: (2019)

Cognitive and neuropsychiatric endophenotypes in amyotrophic lateral sclerosis
por: Costello, Emmet, et al.
Publicado: (2023)

African Ancestry Is a Predictor Factor to Secondary Progression in Clinical Course of Multiple Sclerosis
por: Ferreira Vasconcelos, Claudia Cristina, et al.
Publicado: (2012)

Neuropsychiatric symptoms of multiple sclerosis: A case report
por: Dos Santos, P. Espada, et al.
Publicado: (2021)

Cholangiocarcinoma associated with limbic encephalitis and early cerebral abnormalities detected by 2-deoxy-2-[fluorine-18]fluoro-d-glucose integrated with computed tomography-positron emission tomography: a case report
por: Schmidt, Sergio L., et al.
Publicado: (2016)

Translation, cross-cultural adaptation and validation of the Portuguese version of the DYMUS questionnaire for the assessment of dysphagia in multiple sclerosis
por: Sales, Déborah S, et al.
Publicado: (2013)

Everolimus for treatment of tuberous sclerosis complex‐associated neuropsychiatric disorders
por: Krueger, Darcy A., et al.
Publicado: (2017)

Quality of life, disability, and clinical variables in amyotrophic lateral sclerosis
por: Alencar, Mariana Asmar, et al.
Publicado: (2021)

Effect of handedness on auditory attentional performance in ADHD students
por: Schmidt, Sergio L, et al.
Publicado: (2017)

Influence of gut microbiota on neuropsychiatric disorders
por: Cenit, María Carmen, et al.
Publicado: (2017)

Cardiometabolic Effects of Antipsychotics in Challenging Behavior and Neuropsychiatric Symptoms in Patients With Intellectual Disability
por: Takano, Tomoyuki
Publicado: (2023)

Dementia caregiver burgen in a brasilian sample: Association to neuropsychiatric symptoms
por: Fialho, Patrícia Paes Araujo, et al.
Publicado: (2009)

Morphostructural MRI Abnormalities Related to Neuropsychiatric Disorders Associated to Multiple Sclerosis
por: Bonavita, Simona, et al.
Publicado: (2013)

Neuropsychiatric and cognitive effects of the COVID-19 outbreak on multiple sclerosis patients
por: Haji Akhoundi, Fahimeh, et al.
Publicado: (2020)

Neuropsychiatric manifestations of depression in multiple sclerosis: neuroinflammatory, neuroendocrine, and neurotrophic mechanisms in the pathogenesis of immune-mediated depression
por: Pucak, Michele L., et al.
Publicado: (2007)

Behavioral disorder in people with an intellectual disability and epilepsy: A report of the Intellectual Disability Task Force of the Neuropsychiatric Commission of ILAE
por: Kerr, Mike, et al.
Publicado: (2016)

Direct and indirect costs of Multiple Sclerosis in Baix Llobregat (Catalonia, Spain), according to disability
por: Casado, Virginia, et al.
Publicado: (2006)

Association of caregiver demographic variables with neuropsychiatric symptoms in Alzheimer’s disease patients for distress on the Neuropsychiatric Inventory (NPI)
por: Godinho, Cláudia, et al.
Publicado: (2008)

New insights into the pathogenesis and prevention of tuberous sclerosis-associated neuropsychiatric disorders (TAND)
por: Gipson, Tanjala T., et al.
Publicado: (2017)

COVID-19 Patients with Early Gastrointestinal Symptoms Show Persistent Deficits in Specific Attention Subdomains
por: Schmidt, Juliana, et al.
Publicado: (2023)

Cortical fractal dimension predicts disability worsening in Multiple Sclerosis patients
por: Roura, Eloy, et al.
Publicado: (2021)

Cognitive assessment of Brazilian patients with multiple sclerosis: weighing the impact of disability and depressive symptoms
por: Andrade, Patricia Semionato, et al.
Publicado: (2022)

Symptom rates and profile clustering in tuberous sclerosis complex-associated neuropsychiatric disorders (TAND)
por: Alperin, Samuel, et al.
Publicado: (2021)

Impairment, disability and fatigue in multiple sclerosis
por: Shahrbanian, Shahnaz, et al.
Publicado: (2018)

Neuropsychiatric risk in children with intellectual disability of genetic origin: IMAGINE, a UK national cohort study
por: Wolstencroft, Jeanne, et al.
Publicado: (2022)

Confirmed disability progression as a marker of permanent disability in multiple sclerosis
por: Sharmin, Sifat, et al.
Publicado: (2022)

Acetate correlates with disability and immune response in multiple sclerosis
por: Pérez-Pérez, Silvia, et al.
Publicado: (2020)

Is There a Future for PPARs in the Treatment of Neuropsychiatric Disorders?
por: Tufano, Michele, et al.
Publicado: (2020)

New Advances in Neuropsychiatric Disorders of Childhood and Adolescence
por: Roccella, Michele, et al.
Publicado: (2022)

Editorial: Chronic pain in neuropsychiatric diseases
por: Adamo, Daniela, et al.
Publicado: (2023)

Post-COVID-19 olfactory dysfunction: carbamazepine as a treatment option in a series of cases
por: Vasconcelos, Claudia Cristina Ferreira, et al.
Publicado: (2022)

Neuropsychiatric symptoms in brain diseases - historical foundations
por: Engelhardt, Eliasz, et al.
Publicado: (2020)

The Landscape of Humoral Immunity in the CSF of COVID-19 Patients With Neuropsychiatric Involvement
por: Bartley, Christopher, et al.
Publicado: (2021)

Patient-ventilator asynchrony
por: Holanda, Marcelo Alcantara, et al.
Publicado: (2018)

A systematic review of neuropsychiatric and cognitive assessments used in clinical trials for amyotrophic lateral sclerosis
por: Beswick, Emily, et al.
Publicado: (2020)

International consensus recommendations for the identification and treatment of tuberous sclerosis complex-associated neuropsychiatric disorders (TAND)
por: de Vries, Petrus J., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_6djbgtrfkesg92ptem9lft44qd